Clinical Cancer Research · 2014 · 136 citations · 34 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTumor ProgressionBone MetastasisCancer Stem CellsMetastatic Bone DiseaseMicrorna BiologyMolecular Tumor ProfilingProstate CancerEpithelial-mesenchymal Transition MarkersGleason ScoringHuman Embryonic Stem CellsMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna Regulation Of EmtProstate Carcinogenesis
PURPOSE: miR-409-3p/-5p is a miRNA expressed by embryonic stem cells, and its role in cancer biology and metastasis is unknown. Our pilot studies demonstrated elevated miR-409-3p/-5p expression in human prostate cancer bone metastatic cell lines; therefore, we defined the biologic impact of manipulation of miR-409-3p/-5p on prostate cancer progression and correlated the levels of its expression with clinical human prostate cancer bone metastatic specimens. EXPERIMENTAL DESIGN: miRNA profiling of a prostate cancer bone metastatic epithelial-to-mesenchymal transition (EMT) cell line model was performed. A Gleason score human tissue array was probed for validation of specific miRNAs. In addition, genetic manipulation of miR-409-3p/-5p was performed to determine its role in tumor growth, EMT, and bone metastasis in mouse models. RESULTS: Elevated expression of miR-409-3p/-5p was observed in bone metastatic prostate cancer cell lines and human prostate cancer tissues with higher Gleason scores. Elevated miR-409-3p expression levels correlated with progression-free survival of patients with prostate cancer. Orthotopic delivery of miR-409-3p/-5p in the murine prostate gland induced tumors where the tumors expressed EMT and stemness markers. Intracardiac inoculation (to mimic systemic dissemination) of miR-409-5p inhibitor-treated bone metastatic ARCaPM prostate cancer cells in mice led to decreased bone metastasis and increased survival compared with control vehicle-treated cells. CONCLUSION: miR-409-3p/-5p plays an important role in prostate cancer biology by facilitating tumor growth, EMT, and bone metastasis. This finding bears particular translational importance as miR-409-3p/-5p appears to be an attractive biomarker and/or possibly a therapeutic target to treat bone metastatic prostate cancer.
34
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz et al. · Science Signaling · 2013 · 15.9K citations · Full text
Medicine, Bioinformatics, Oncology +17
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor, Nikolaus Schultz, Haley Hieronymus et al. · Cancer Cell · 2010 · 3.8K citations · Full text
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Li Ma, Julie Teruya‐Feldstein, Robert A. Weinberg · Nature · 2007 · 2.6K citations
Medicine, Cancer Biology, Oncology +12
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie, Claudio R. Alarcón, Thórdur Óskarsson et al. · Nature · 2008 · 1.9K citations · Full text